Purpose of the Procedure
- Early detection of ovarian cancer in its initial stages.
- Differentiating between benign and malignant pelvic masses.
- Monitoring patient response to chemotherapy or surgery.
Book HE4 Ovarian Cancer Test | Lahalak Medical Platform
Prioritize your wellness with the HE4 assay, a highly sensitive biomarker for early detection and monitoring of ovarian cancer, offering superior accuracy and fewer false positives than traditional tests.
Scientific name: Human Epididymis Protein 4 (HE4) Assay
A specialized blood test measuring HE4 protein levels to assess ovarian cancer risk. It provides superior sensitivity for early-stage detection and helps differentiate between benign and malignant pelvic masses.
Service type
Laboratory test
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- Blood sample collection
- Precise HE4 protein lab analysis
- Results report
Medical Service Information
Advantages of HE4 Testing
- Higher sensitivity than the traditional CA-125 test in early stages.
- Less likely to be affected by benign conditions like endometriosis.
- Provides high accuracy in ovarian tumor risk assessment.
Target Groups
- Women presenting with a pelvic mass.
- Women with a family history of ovarian cancer.
- Patients undergoing ovarian cancer treatment for monitoring.
Conditions & Notices
- Advised to inform the doctor of any current medications
Medical services you might also like
